P&G Takes ‘Raising The Bar’ Too Far In Superiority Claim For Olay Over Dove – NAD
This article was originally published in The Tan Sheet
P&G can use in future ads, at best, a qualified version of the least assertive claim used in print and online for Olay Ultra Moisture bar soap, NAD recommends. According to Unilever, P&G’s advertising, considered in its totality, communicated an unsubstantiated message that Olay is superior to the Dove white bar.
You may also be interested in...
Cannabidiol (CBD) represents an intriguing opportunity for cosmetics, without the statutory obstacles faced by food and dietary supplement companies. Cosmetics marketers are taking advantage, but the FDA’s recent warning letter blitz is a reminder that CBD-infused beauty products are bound by the same rules that apply to other cosmetics.
Federal preemption of state and local requirements that differ from federal mandates came up repeatedly at the House Energy & Commerce Health Subcommittee’s 4 December cosmetics hearing. Meanwhile, both NGO and industry stakeholders generally support FDA review of cosmetic ingredients, but the details of such a framework likely will be contentious as work progresses.
House Energy & Commerce Committee Chairman Frank Pallone underscores FDA’s lack of resources and insufficient “regulatory tools” in a memo to Health Subcommittee members going into a 4 December hearing on cosmetics safety issues. The committee’s last hearing on the subject was in 2012 when Pallone unveiled the first version of his Cosmetics Safety Enhancement Act.